Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins

This article explores the promise and challenges of digital twins for personalized radiopharmaceutical therapy, focusing on ethical, regulatory, and technical issues in nuclear oncology.

Educational Objectives

Educational Aim:

Enhancing participants' understanding of the ethical, regulatory, and technical considerations in developing and implementing theranostic digital twins for personalized radiopharmaceutical therapy, equipping them to critically evaluate challenges and solutions for responsible clinical adoption.

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

1. The ethical, regulatory, and technical challenges in developing theranostic digital twins for personalized radiopharmaceutical therapy.
2. The importance of data privacy, security, and patient consent in implementing digital twin technologies in nuclear oncology.
3. Strategies to address barriers and promote responsible, equitable adoption of digital twins in clinical practice.

Instructions for this Module

• Read the supplied reading material and complete the quiz that follows;
• You have three attempts to pass the quiz;
• The pass grade is 70%;
• You need to pass the quiz to claim your CPD certificate;
• Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

If you need any assistance to complete this module, please Contact us